Table 1.
Baseline characteristics of 75 HCC patients in this study
| Variables | Values | Percent |
|---|---|---|
| Age (years) | ||
| Mean ± SD (median) | 61.6±8.1 (60) | |
| Range (95% CI) | 43–81 (59.7–63.5) | |
| Sex | ||
| Females | 29 | 38.7 |
| Males | 46 | 61.3 |
| Ethnicity | ||
| Asian | 72 | 96 |
| Caucasian | 3 | 4 |
| Clinical symptoms | ||
| Weight loss | 66 | 88 |
| Abdominal discomfort | 60 | 80 |
| Abdominal pain | 12 | 16 |
| Fatigue | 68 | 90.7 |
| Liver cirrhosis | 71 | 94.7 |
| Child-Pugh A | 12 | 16 |
| Child-Pugh B | 38 | 50.6 |
| Child-Pugh C | 25 | 33.4 |
| Mean ALT (U/L) | 74.3 | 16.7 |
| Mean AST (U/L) | 135.2 | 7.2 |
| Viral hepatitis | ||
| HBV+ | 23 | 30.7 |
| HCV+ | 34 | 45.3 |
| Dual HBV+/HCV+ | 9 | 12 |
| Negative | 4 | 5.3 |
| Missing data | 5 | 6.7 |
| AFP | 75 | 100 |
| ≤40 IU/mL | 19 | 25.3 |
| ≤200 IU/mL | 36 | 48 |
| ≤1,000 IU/mL | 53 | 70.6 |
| Mean ± SD (median) | 4,333±13,243 (245.2) | |
| Range (95% CI) | 7.2–92,407 (1,186–7,280) | |
| Tumor | ||
| Single (<3 cm) | 0 | 0 |
| Single (>3 cm) | 7 | 9.3 |
| Multifocal | 51 | 68.1 |
| Missing data | 17 | 22.6 |
Abbreviations: AFP, alpha-fetoprotein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CI, confidence interval; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; SD, standard deviation.